Valuation: Solventum Corporation

Capitalization 14.86B 12.77B 11.91B 11.07B 20.65B 1,342B 22.27B 137B 53.8B 641B 55.74B 54.6B 2,366B P/E ratio 2025 *
8.8x
P/E ratio 2026 * 26.7x
Enterprise value 18.32B 15.74B 14.68B 13.64B 25.45B 1,655B 27.45B 169B 66.32B 791B 68.71B 67.3B 2,916B EV / Sales 2025 *
2.21x
EV / Sales 2026 * 2.22x
Free-Float
80.04%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-6.61%
1 week-3.76%
Current month+1.00%
1 month-3.56%
3 months+12.91%
6 months+8.44%
Current year+1.00%
More quotes
1 week 79.6
Extreme 79.6001
86.36
1 month 78.18
Extreme 78.1847
86.36
Current year 78.18
Extreme 78.1847
86.36
1 year 60.7
Extreme 60.7
88.2
3 years 47.16
Extreme 47.16
96.05
5 years 47.16
Extreme 47.16
96.05
10 years 47.16
Extreme 47.16
96.05
More quotes
Change 5d. change 1-year change 3-years change Capi.($)
-6.61%-3.76%+16.82% - 14.86B
-0.27%-2.72%+9.82%+9.51% 217B
-0.55%-3.88%+17.89%+19.64% 124B
+1.09%-0.08%+46.50%+110.54% 66.38B
-0.60%-1.87%-14.68%-21.24% 57.76B
+3.41%+5.52%+26.36%+93.79% 53.49B
+0.30%+7.74% - - 35.55B
-1.03%+0.52%-12.01%-35.24% 27.68B
-0.35%-0.06%+25.32%+28.63% 25.59B
-0.14%+0.14%+7.03%-32.27% 24.43B
Average -0.48%+2.83%+13.67%+21.67% 64.68B
Weighted average by Cap. -0.05%+1.05%+14.29%+24.48%
See all sector performances

Financials

2025 *2026 *
Net sales 8.27B 7.11B 6.63B 6.16B 11.49B 747B 12.39B 76.21B 29.94B 357B 31.02B 30.39B 1,317B 7.99B 6.86B 6.4B 5.95B 11.1B 721B 11.96B 73.57B 28.91B 345B 29.95B 29.34B 1,271B
Net income 1.6B 1.38B 1.29B 1.19B 2.23B 145B 2.4B 14.77B 5.8B 69.21B 6.01B 5.89B 255B 1.01B 871M 812M 755M 1.41B 91.52B 1.52B 9.34B 3.67B 43.74B 3.8B 3.72B 161B
Net Debt 3.46B 2.97B 2.77B 2.58B 4.81B 312B 5.18B 31.86B 12.52B 149B 12.97B 12.7B 551B 2.87B 2.47B 2.3B 2.14B 3.99B 260B 4.3B 26.47B 10.4B 124B 10.78B 10.56B 457B
More financial data * Estimated data
Logo Solventum Corporation
Solventum Corporation specializes in the marketing of tools used in the medical field. Net sales break down by family of products as follows: - medical instruments and accessories (56.2%): for wound care, sterilization, surgery, etc.; - medical information systems (15.8%): including software solutions for documentation, billing, coding, data visualization, etc. in hospital environments; - dental and orthodontic instruments and accessories (15.7%): for dental care and restoration; - purification and filtration instruments (11.6%): used in the medical, bio-pharmaceutical, agri-food and other sectors; - other (0.7%). The United States accounts for 57.5% of net sales.
Employees
22,000
More about the company
Date Price Change Volume
26-01-13 80.03 $ -6.61% 1,678,257
26-01-12 85.69 $ -0.52% 773,045
26-01-09 86.14 $ +0.43% 741,491
26-01-08 85.77 $ +1.82% 1,191,058
26-01-07 84.24 $ +1.30% 1,026,039

Delayed Quote Nyse, January 13, 2026 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
80.03USD
Average target price
87.18USD
Spread / Average Target
+8.94%
Consensus

Quarterly revenue - Rate of surprise